Enhance MD vs bmiMD: Pricing, Compounds, and Subscription Choices
Quick verdict: For lowest first-month cost and a platform that offers both semaglutide and tirzepatide, Enhance MD is the clear choice; for lower long-term per-month pricing via multi month commitments and free shipping, bmiMD stands out.
Start with Enhance MD’s $49 first month offer
Enhance MD vs bmiMD: what the comparison focuses on
The primary differences between Enhance MD and bmiMD in the supplied material are introductory pricing, compounds offered, ongoing pricing structure and subscription options, and shipping and support features. Both providers use clinician review and offer compounded medications, with the regulatory note that compounded medications are not FDA approved and are not reviewed by FDA for safety, effectiveness or quality.
1. Introductory price and immediate cost
Enhance MD lists semaglutide from $49 for the first month and tirzepatide from $99 for the first month. Those are explicitly first month introductory prices. bmiMD lists tirzepatide month to month at $179, with lower monthly equivalents if you commit to multi month plans down to $139 per month for a 12 month plan. The comparison is direct: Enhance MD offers a notably lower first month on semaglutide and tirzepatide, while bmiMD’s lowest published per month requires a 12 month commitment.
See bmiMD tirzepatide plan options and pricing
2. Compounds available and platform breadth
Enhance MD offers both compounded semaglutide and compounded tirzepatide on one platform, which the source notes can be useful for patients deciding between the two compounds. bmiMD’s captured evidence focuses on compounded tirzepatide and related subscription options. Both include the regulatory qualifier that compounded medications are not FDA approved and are not reviewed by FDA for safety, effectiveness or quality.
3. Ongoing pricing structure and commitments
Enhance MD emphasizes flat rate pricing that stays the same at every dose with no fee escalation during titration after the introductory period. The source states that ongoing flat rate pricing may be higher than the introductory price and that ongoing flat rate pricing is not always prominently published before intake. bmiMD provides four billing options and advertises lower long term monthly equivalents if you select multi month plans, but notes that the lowest price requires a 12 month commitment and that total prepaid charges should be confirmed. This is a core difference: Enhance MD promotes no dose based escalation; bmiMD offers subscription discounts tied to longer commitments.
Compare Enhance MD flat rate pricing details
4. Shipping, clinician access, and refill logistics
bmiMD highlights free subscription shipping on every subscription order, online refills and 24/7 clinician access in the captured content. Enhance MD’s captured content emphasizes clinician directed care and metabolic lab testing every six months in some published pricing rows, but does not include a specific free shipping claim in the supplied evidence. Both sources note availability is subject to clinician review and medical appropriateness.
5. Scale and claimed experience
Enhance MD states it has treated more than 10,000 patients in its supplied material, presented as clinician reviewed platform volume. bmiMD’s captured content includes testimonial style language about turnaround time and outcomes, and emphasizes its state licensed pharmacy preparation and independent verification in FDA and DEA registered labs, as presented in the captured landing page text. Both retain the compounded regulatory note.
Comparison table
| Criteria | Enhance MD | bmiMD |
|---|---|---|
| Introductory pricing | Semaglutide from $49 first month; tirzepatide from $99 first month | Tirzepatide $179 month to month; lower with multi month plans |
| Compounds offered | Compounded semaglutide and tirzepatide on one platform | Compounded tirzepatide focus in captured content |
| Ongoing pricing model | Flat-rate pricing, same price at every dose after intro | Multi month plans lower monthly equivalent; lowest needs 12 month commitment |
| Shipping and refills | Clinician directed care and metabolic lab testing noted; shipping not specified in captured facts | Free subscription shipping; online refills and delivery |
| Clinician review and regulatory note | Treatment available only when a licensed clinician determines it is medically appropriate; compounded meds not FDA approved | Treatment available only when a licensed clinician determines it is medically appropriate; compounded meds not FDA approved |
How to choose between Enhance MD vs bmiMD
If your priority is the lowest first month entry price and a single platform that offers both semaglutide and tirzepatide, Enhance MD’s explicit semaglutide from $49 first month and tirzepatide from $99 first month with flat rate pricing may be preferable. If you plan to commit long term and want lower per month equivalent pricing plus free subscription shipping, bmiMD’s multi month pricing that drops to $139 per month for a 12 month plan may be a better fit. Remember that both providers present compounded medications and that treatment is available only when a licensed clinician determines it is medically appropriate.
View bmiMD subscription plans and shipping
Review Enhance MD compound options and pricing
Choose one if
- Choose Enhance MD if you prioritize the lowest first month price for semaglutide or tirzepatide and want a platform that offers both compounds with flat rate pricing and no dose escalation claims.
- Choose bmiMD if you want lower long term monthly equivalents through multi month commitments, free subscription shipping, and online refill delivery as described in the captured content.
Both providers require clinician review and present compounded medications that are not FDA approved and are not reviewed by FDA for safety, effectiveness or quality. Review eligibility, total charges, and state availability before enrolling.